Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 1
1947 1
1948 3
1951 1
1953 2
1957 1
1958 1
1960 1
1962 2
1965 3
1966 2
1967 1
1968 1
1969 2
1971 2
1972 1
1975 1
1976 2
1979 1
1980 1
1981 2
1982 2
1983 1
1984 1
1985 1
1987 1
2000 1
2005 3
2006 4
2007 3
2008 7
2009 8
2010 8
2011 4
2012 7
2013 10
2014 7
2015 8
2016 3
2017 4
2018 10
2019 12
2020 9
2021 5
2022 8
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Wrangle JM, Velcheti V, Patel MR, Garrett-Mayer E, Hill EG, Ravenel JG, Miller JS, Farhad M, Anderton K, Lindsey K, Taffaro-Neskey M, Sherman C, Suriano S, Swiderska-Syn M, Sion A, Harris J, Edwards AR, Rytlewski JA, Sanders CM, Yusko EC, Robinson MD, Krieg C, Redmond WL, Egan JO, Rhode PR, Jeng EK, Rock AD, Wong HC, Rubinstein MP. Wrangle JM, et al. Among authors: hill eg. Lancet Oncol. 2018 May;19(5):694-704. doi: 10.1016/S1470-2045(18)30148-7. Epub 2018 Apr 5. Lancet Oncol. 2018. PMID: 29628312 Free PMC article. Clinical Trial.
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers.
Rubinstein MP, Williams C, Mart C, Beall J, MacPherson L, Azar J, Swiderska-Syn M, Manca P, Gibney BC, Robinson MD, Krieg C, Hill EG, Taha SA, Rock AD, Lee JH, Soon-Shiong P, Wrangle J. Rubinstein MP, et al. Among authors: hill eg. J Immunol. 2022 Mar 15;208(6):1362-1370. doi: 10.4049/jimmunol.2100066. Epub 2022 Feb 28. J Immunol. 2022. PMID: 35228263 Clinical Trial.
Patient Navigation for Timely, Guideline-Adherent Adjuvant Therapy for Head and Neck Cancer: A National Landscape Analysis.
Graboyes EM, Chappell M, Duckett KA, Sterba K, Hughes Halbert C, Hill EG, Chera B, McCay J, Puram SV, Ramadan S, Sandulache VC, Kahmke R, Nussenbaum B, Alberg AJ, Paskett ED, Calhoun E. Graboyes EM, et al. Among authors: hill eg. J Natl Compr Canc Netw. 2023 Dec;21(12):1251-1259.e5. doi: 10.6004/jnccn.2023.7061. J Natl Compr Canc Netw. 2023. PMID: 38081134
Delays Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients: A Systematic Review and Meta-analysis.
Duckett KA, Kassir MF, Nguyen SA, Brennan EA, Chera BS, Sterba KR, Hughes Halbert C, Hill EG, McCay J, Puram SV, Sandulache VC, Kahmke R, Ramadan S, Nussenbaum B, Alberg AJ, Graboyes EM. Duckett KA, et al. Among authors: hill eg. Otolaryngol Head Neck Surg. 2024 Feb;170(2):320-334. doi: 10.1002/ohn.538. Epub 2023 Sep 20. Otolaryngol Head Neck Surg. 2024. PMID: 37731255 Review.
Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer.
Riesenberg BP, Hunt EG, Tennant MD, Hurst KE, Andrews AM, Leddy LR, Neskey DM, Hill EG, Rivera GOR, Paulos CM, Gao P, Thaxton JE. Riesenberg BP, et al. Among authors: hill eg. Cancer Res. 2022 Dec 2;82(23):4386-4399. doi: 10.1158/0008-5472.CAN-22-1744. Cancer Res. 2022. PMID: 36126165 Free PMC article.
HUNK phosphorylates EGFR to regulate breast cancer metastasis.
Williams CB, Phelps-Polirer K, Dingle IP, Williams CJ, Rhett MJ, Eblen ST, Armeson K, Hill EG, Yeh ES. Williams CB, et al. Among authors: hill eg. Oncogene. 2020 Jan;39(5):1112-1124. doi: 10.1038/s41388-019-1046-5. Epub 2019 Oct 9. Oncogene. 2020. PMID: 31597954 Free PMC article.
Correction: HUNK phosphorylates EGFR to regulate breast cancer metastasis.
Williams CB, Phelps-Polirer K, Dingle IP, Williams CJ, Rhett MJ, Eblen ST, Armeson K, Hill EG, Yeh ES. Williams CB, et al. Among authors: hill eg. Oncogene. 2021 May;40(20):3635-3636. doi: 10.1038/s41388-021-01797-3. Oncogene. 2021. PMID: 33958726 Free PMC article. No abstract available.
155 results